A new COVID-19 variant, known as Cicada and scientifically known as BA.3.2, has emerged in some of these countries, and health officials are closely monitoring this variant as it has a large number of mutations, especially in the spike protein, which could make it more capable of escaping immunity from vaccines or past infections. But while the numbers remain lower than in other waves, its spread has been worrying researchers too.
Where it has been Detected
The Cicada variant has been detected in at least 25 states in the United States and in 23 countries worldwide. Countries in Europe confirm that the variant is present with Italy, the United Kingdom, Germany, France, Spain, the Netherlands, and South Korea. Canada, Australia, Japan, and South Korea also detected the variant. In the Middle East, Israel and the United Arab Emirates detected the variant, and Brazil and Mexico confirmed its presence in Latin America. And there's a broad geographic spread, so new variants can quickly evolve across borders.
Symptoms and Health Impact
Cicada symptoms are similar to other Omicron-lineage variants. Most cases can be fever, sore throat, cough, fatigue, headache, and congestion. There are also muscle aches and mild gastrointestinal issues. So far, all infections have been mild, but health workers must be cautious, especially for older groups (the elderly and those with underlying conditions) and those with associated diseases. Vaccines provide strong protection against severe disease and hospitalization.
Why Experts Are Concerned
Cicada has more than 70 mutations in its spike protein, which raises the possibility that it could spread more easily or undermine immunity from vaccines and past infections. There is no evidence yet that Cicada leads to more severe disease, so its ability to spread rapidly is a concern. The World Health Organization (WHO) and the Centers for Disease Control and Prevention (CDC) are closely watching it.
Precautions and Recommendations
Health professionals are calling on people to remain vigilant in the same spirit of precautions. Vaccination and booster doses are still the best protection against severe illness. Wearing masks in crowded places, practicing good hand hygiene, and testing when symptoms appear are still important steps. Governments are also advising travelers that they should keep an eye on health advisories, especially if in countries where Cicada has been detected.
Global Context
Cicada’s emergence is one of the signs that COVID-19 is still evolving. Overall case numbers are down, but new variants can appear and spread quickly, which shows that countries are strengthening surveillance measures to detect variants early and respond effectively. Public health agencies stress that panic is not required and we need vigilance.
Cicada is not yet in full momentum in the global picture, but its spread across 23 countries makes it worth monitoring. There are still vaccines in place, and they can still help our population with control and preparedness. Cicada is just a reminder that the pandemic isn't over together with global cooperation for prevention.
